-
EDITORIAL
Therapeutic oligonucleotides: the promises are up for delivery
J. Wengel
-
SUSTAINABILITY
A new guideline harmonises product carbon footprint calculations for chemicals
J. Christ, V. Buback
-
SUSTAINABILITY
How to develop a CO2-neutral bioprocess
P. Arbter
-
OLIGONUCLEOTIDES & PEPTIDES
Oligonucleotide therapeutics. A long and windy road towards future medicines
R. Eritja, C. Fabrega
-
OLIGONUCLEOTIDES & PEPTIDES
Synthetic Chemistry in Nucleic Acid Drugs Recent progress in bridged nucleic acids (BNA)
K. Okano
-
OLIGONUCLEOTIDES & PEPTIDES
Oligonucleotides: Right Place, Right time, Right future
T. Martinez
-
COLUMN: QUALITY & SUPPLY CHAIN SECURITY
Building skills to power a data-first regulatory ecosystem
R. Rjavec
-
COLUMN: QUALITY & SUPPLY CHAIN SECURITY
Building transparency into pharmaceutical supply chains with discoverable and verifiable Web3 assets
C. Soulsby
-
MEDICAL DEVICE
Applications of polymeric resins in medical devices for life saving treatments
A. Basso
-
EXCIPIENTS
Titanium Dioxide: updates
K. Hughes
-
EXCIPIENTS
Topical drug delivery and the role of excipients
M. E. Herbig
-
FLOW CHEMISTRY
Progress in flow chemistry
R. Ashe
-
Column: REGULATION
REACH REGULATION: What’s new about polymers
A. Conto
-
PHARMA SUPPLY CHAIN
Particle Engineering to Optimise the Performance of Inhaled Therapeutics
L. S. Daintree, P. York
-
PHARMA SUPPLY CHAIN
Integrating Quality into production to drive cost-effective innovation
E. Cayòn
-
CLINICAL TRIALS
Survey finds high levels of early adoption of EMA’s centralized clinical trials information system
N. Kidman, K. O’donnell
-
COLUMN: API OF THE MONTH
Tapinarof
R. Souza
-
QUALITY & SUPPLY CHAIN SECURITY
Are agile supply chain management and blockchain beneficial to industry and patients? Focus group with healthcare and pharmaceutical professionals. Part 2
A. Pesqueira
